NarcX® is the safe and cost-effective method to dispose of drugs, and here's why it's better than traditional collection receptacles:
1) NarcX products do not require incineration or pickup by a contract carrier or DEA reverse distributor. It follows 21 CFR Part 1317 requirements.
2) The reduction of steps helps eliminate any diversion potential.
3) Staff doesn't have to open locked doors to check the fill level, as the viewing window indicates when the container is full.
4) Authorized collector locations will only pay for actual drug destruction vs. packaging.
5) The facility does not have to wait for Certificates of Destruction from DEA reverse distributor as this takes place on-site.
6) It is less expensive to run NarcX versus traditional collection receptacles.
NarcX on-site drug disposal solution is easy to use, so facilities do not have to worry about improperly disposing of drugs or trying to keep others safe while around this disposal solution.
NarcX® was founded to combat the diversion of narcotics, amphetamines, opiates and other frequently-abused controlled substances and to provide a convenient and affordable disposal option for unused, unwanted or expired tablets, capsules and liquid medications.
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Drug Diversion Monitoring, Diversion Prevention Returns, Reverse Distribution
